A: Viagra 100mg Tablet is primarily used to manage erectile dysfunction (ED) in men by increasing blood flow to the penis, helping men achieve and maintain an erection during sexual activity.
A: No, Viagra 100mg Tablet is a prescription medication and should only be used under the supervision of a healthcare provider. It is essential to consult a doctor to determine the appropriate dosage and ensure safety. Do not self-use Viagra or any ED pills without proper doctor consultation. FDA warns consumers not to use unapproved erectile dysfunction products as they may cause serious side effects like chest pain, fainting, etc.
A: No, Viagra 100mg should not be taken daily. It is typically used on an as-needed basis, with a recommended maximum dose of one tablet per day. Overuse can increase the risk of side effects.
A: Yes, Viagra is an effective for erectile dysfunction (ED) in men. It works by increasing blood flow to the penis, helping men achieve and sustain an erection when sexually stimulated.
A: The best time to take Viagra is approximately 1 hour before sexual activity. However, it can be taken between 30 minutes and 4 hours in advance for optimal effectiveness. Avoid taking it right after a heavy meal, as it may delay its onset.
A: The maximum recommended dose of Viagra is 100mg per day. Do not take more than one dose within a 24-hour period. Always follow your doctor’s recommendations.
A: It is generally not recommended to split a Viagra 100mg tablet unless instructed by your doctor. If a lower dose is required, your doctor may prescribe a 50mg or 25mg dose instead.
A: Viagra can cause a drop in blood pressure, which may be risky for people with certain heart conditions, especially if taken with nitrates or other medications for heart disease. Always consult a doctor before using Viagra if you have a history of heart problems.
A: In rare cases, Viagra has been associated with sudden vision loss due to a condition called non-arteritic anterior ischemic optic neuropathy (NAION). If you experience sudden vision changes or loss, stop taking Viagra and seek immediate medical attention.
A: Viagra can be safe for older adults, but dosage adjustments may be necessary, especially if they have underlying health conditions like heart disease or liver problems. It’s important for older adults to consult their doctor before using Viagra.
A: Common side effects in men taking Viagra 100mg may include headache, flushing, dizziness, blurred vision, and indigestion. If any side effects persist or cause discomfort, consult your doctor.
A: Viagra typically starts working within 30 minutes to 1 hour after ingestion. The exact time may vary depending on factors like food intake, metabolism, and individual response.
A: The effects of Viagra generally last for about 4 to 5 hours. However, the duration may vary depending on the individual, and Viagra will only work with sexual stimulation.
ThisADIHow long does Viagra take to work? It usually starts to work within 30 minutes to one hour and is rapidly absorbed into the bloodstream. If it is not effective and the effects last longer than that, contact your doctor.
Men in the U. S. can buy over-the-counter (OTC) Viagra at a Canadian Pharmacy without a prescription. But will the drug's makers really give up on Viagra?
In February 2019, Pfizer Inc. announced that the Canadian drug giant would close its Canadian operation. The drug's Canadian name is Pfizer's "Viagra" or "sildenafil" or "generic Viagra."
The move comes after the Canadian company announced it would discontinue the OTC sales of Viagra in 2019. The drug has become popular in the U. for treating erectile dysfunction and helping men regain sexual performance.
This leaves the question: What will the Canadian industry do to keep the drug from going generic?
In a statement, Pfizer Inc. said that Pfizer will not sell Viagra in the U. or any other country. But it will keep a small stake in the company.
"Pfizer and Canadian partners continue to work together to maintain a strong and consistent relationship as we work to grow our business, while ensuring Canadians have access to affordable Viagra and other prescription medications," Pfizer said.
The Canadian company said it plans to discontinue its OTC use in 2019.
"To date, Pfizer has not responded to requests for comment," it said in a statement.
Pfizer said that its Canadian operations will remain in operation.
Pfizer Canada Inc. said in a statement that it has "limited knowledge" of the OTC nature of the Canadian drug, but "will continue to evaluate the status and availability of Viagra products and other medicines," including Viagra.
In an email to CBS News, Pfizer Canada CEO Richard Hamblen said Pfizer will continue to "promote, operate and supply Viagra and other prescription medications through Canadian pharmacies, including and all OTC products, without a prescription."
Copyright 2011 CBS Radio Inc. All Rights ReservedCBS/APThe above statements have not been in any form or shape form, and are intended to be public or to provide a complete overview of the Canadian drug industry and the company's operations. These statements have been evaluated by the Canadian Board of Directors and other regulatory agencies, and should not be considered as public or as a substitute for professional medical advice, diagnosis or treatment.
CBS News
CBS |
This article was written by CBSNews.com's Matt Leão, M. D., and is based on the.
Copyright © 2011 CBS Radio Inc. All rights reserved. This programming is licensed to CBSNews.com and is copyrighted by CBS Corporation. All Rights Reserved.By:
The UK’s top healthcare provider said the drug was prescribed to its users by a private company, and that the price was to be paid by them, even though it is illegal in the country. It was found that it was the first drug to be sold in the UK.
Doctors in the UK have been accused of selling the little blue pill to ‘vulnerable’ patients, after it was discovered it was given to the ‘over-the-counter’ product which was sold over the counter, said the MHRA. The MHRA is a national regulator that regulates the pharmaceutical industry, and it has been investigating the sale of drugs containing the active ingredient sildenafil, the ingredient used in Viagra. Sildenafil is used to treat erectile dysfunction and is used for male sexual performance. The MHRA is a national healthcare agency, and it regulates the pharmaceutical industry, and it is a national regulator. It regulates all pharmaceutical products.
The MHRA said the drug was sold by private companies, and that it would be “intended to provide a safe and effective solution” for “patients suffering from erectile dysfunction, and other health conditions.” It is being investigated by the Department for the Medicines and Healthcare products Regulatory Agency (MHRA), and the Medicines and Healthcare products Regulatory Agency (MHRA) announced that it was selling the drug to patients who are not in accordance with their health conditions.
The MHRA said the drug was being sold under the brand name VIAGRA, which is used in the treatment of erectile dysfunction.
It is being assessed by the MHRA to have been a ‘proprietary’ invention, meaning that the active ingredient was not found to be safe.
In March, the MHRA issued a ‘black box’ warning on the use of the drug in patients with diabetes, heart disease, and certain other health conditions.
The MHRA said the drug was being sold to patients who are not in the UK, as there is no scientific evidence that it is safe.
The MHRA said the product was being sold under the brand name SILDENAFIL. It was found that it was given by a private company to be sold over the counter by the MHRA, and that it was not recommended for sale in the UK.
The MHRA said the drug was being sold to patients “on a risk-benefit basis” and that they should not have to pay for it.
The MHRA said the drug was being sold to patients, under the name VIAGRA, which is used in the treatment of erectile dysfunction.
It was also being assessed by the MHRA to have been a ‘proprietary’ invention, meaning that the active ingredient was not found to be safe.
In September, the MHRA issued a black box warning on the use of the drug in patients with diabetes, heart disease, and certain other health conditions.
The MHRA said it was investigating the sale of the drug to patients who are not in the UK, as there is no scientific evidence that it is safe.
The MHRA said the drug was being sold by private companies, and that it would be “intended to provide a safe and effective solution” for “patients suffering from erectile dysfunction, and other health conditions.”
A recent study revealed a new type of erectile dysfunction (ED) drug that could be taken by women. The study, published in the Journal of Sexual Medicine, found that women with low levels of testosterone had a slightly better quality of life compared to those with normal levels. The study was done after an initial search for a new drug. While it was unclear why the drug was not used in the study, the researchers said, the results could be useful for patients with other conditions.
The drug is not currently approved for use in the U. S. The drug was used in studies of women taking a variety of medications such as Viagra, Cialis and Levitra. The FDA has not approved it for use in the U. The study did not find that the drug caused any side effects. The study was conducted by researchers from the University of California San Diego.
The study was published in the journal Addictive Behaviors. It was published in the Journal of Sexual Medicine on the basis of data from a random sample of over 600 women.
The researchers said their findings may also provide useful information about other medications that could potentially be used for ED. The drug was also used to treat a rare type of cancer called basal cell carcinoma.
The study also found that the drug could have other uses and that it was not approved by the U. Food and Drug Administration for that.
The study also found that the drug was also used as a treatment for erectile dysfunction in children who had had cancer.
In addition, the researchers also found that the drug could have other uses and that it was not approved by the FDA for that.
It was also found that the drug was also used as a treatment for erectile dysfunction in women. The researchers said that this could have other uses and that it could be useful for other conditions as well.
In a world where every day life seems to go horribly wrong, Viagra is at least as old as the earth and is the subject of a major new study by researchers at Columbia University.
This new study, led by researchers from the University of Toronto and from the University of Alberta, found that the erectile dysfunction drug sildenafil, which is often marketed for treatment of erectile dysfunction, is not as effective as a placebo in treating erectile dysfunction.
Researchers from the University of Toronto found that sildenafil did not significantly differ from placebo in the number of users who had trouble getting and maintaining an erection during sexual intercourse, and it did not significantly differ from a placebo in the number of users who needed an erection during intercourse.
Researchers say that the problem is likely due to the drug sildenafil, which is marketed for erectile dysfunction treatment in Canada, while the Food and Drug Administration has not approved the drug.
“Our study suggests that the drug does not work as well as it should in men with erectile dysfunction,” said lead investigator, Dr. Andrew L. McVary.
“The results of the study do not support the belief that the drug can be used to treat ED and treat it differently from a placebo.”
Sildenafil, the active ingredient in Viagra, was first approved by the Food and Drug Administration in 1998. Its effects on erections are thought to last about four to six hours.
This study was published in theJournal of Sexual Medicine.
“We found that the effects of sildenafil did not significantly differ from placebo in erectile function parameters in men with ED who had been taking the drug for more than two months,” McVary said.
“The results of the study also suggest that the drug is unlikely to be a useful treatment for ED, as it is believed to have little or no effect on sexual function in men, or on erectile function in women,” he added.
Although the study does not completely address ED, the study also found that men who took sildenafil had fewer ED symptoms than those who did not.
“This is not the first time that the drug has been associated with ED,” McVary said. “We also found that men with ED who took the drug had a small increased risk of having a serious heart condition or stroke.
“While these results suggest that the drug is unlikely to be useful in treating ED, the results do not suggest that it is superior to the placebo.”
The results were presented at the 20th Annual Meeting of the Society of Biological Psychiatry, held in Toronto in September of 2010.
This report was originally published in the
The study is based on the results of a large clinical trial and was designed to examine the effects of sildenafil in men with ED.
Sildenafil is the active ingredient in Viagra and is sold under the brand name Levitra and is approved for use in Canada by the Food and Drug Administration in 1998.
Dr. McVary is a professor of clinical pharmacology and medicine at the University of Toronto and a senior research fellow in the department of medical science at the University of Alberta.
Stade de France Pharmacy